Scott Barbian
About Scott Barbian
Scott Barbian is an experienced analyst currently working at Inotiv as an Analyst II. He has a background in biology and has held various positions in the biotechnology and research sectors, including roles at Advanced Accelerator Applications and Novartis Institutes for BioMedical Research.
Work at Inotiv
Scott Barbian has been employed at Inotiv as an Analyst II since 2021. In this role, he contributes to various analytical projects and supports the company's research initiatives. His experience in the field allows him to apply his knowledge effectively to enhance operational processes and outcomes.
Previous Experience in Biologics
Before joining Inotiv, Scott Barbian worked as an Associate Biologist at Advanced Accelerator Applications from 2018 to 2021. He also held a similar position at Endocyte from 2016 to 2018. His roles in these companies involved conducting biological research and supporting the development of innovative therapies.
Education and Expertise
Scott Barbian earned a Bachelor of Science (B.S.) degree in Biology from the University of Wisconsin-Platteville, completing his studies from 2006 to 2010. His educational background provides a solid foundation in biological sciences, which he has applied throughout his career in various roles within the life sciences industry.
Career Progression
Scott Barbian's career began as a Laboratory Technician at The Dow Chemical Company in 2014. He then transitioned to a Study Technician II role at Covance from 2011 to 2014. Following this, he worked as a Lawn Care Specialist at TruGreen for a year before moving into biological research positions. His diverse work history reflects a commitment to advancing his expertise in the life sciences sector.
Current Role at Novartis Institutes for BioMedical Research
In addition to his position at Inotiv, Scott Barbian has been working as a Research Scientist I at Novartis Institutes for BioMedical Research (NIBR) since 2020. In this capacity, he engages in research activities that contribute to the development of new biomedical solutions.